Abstract
Whether chronic hepatitis C virus (HCV) infection is a risk factor for the development of bone disease has long been controversial. For this reason, chronic HCV-infected participants (n = 69) were recruited into a prospective cohort study and underwent dual-energy X-ray absorptiometry for determination of bone mineral density (BMD). Fibrosis staging was evaluated according to the noninvasive index FIB-4. T scores at the femoral neck and lumbar spine were used as the primary outcome variables to assess the association between degree of liver disease and BMD. The study cohort was 41 % male with a mean age of 53.6 years. The mean BMD, Z score, and T score values of lumbar spine in chronic hepatitis C (CHC) patients were significantly lower than those in healthy controls (p < 0.001). The rate of osteoporosis for CHC patients aged 45–54 years was significantly higher than that of the control group (p = 0.011). Bone alkaline phosphatase and C-terminal cross-linking telopeptide of type I collagen levels were also significantly higher in CHC patients with reduced BMD. Patients with more advanced liver fibrosis had significantly lower BMD. In conclusion, reduced BMD is common in this population of chronic HCV-infected patients and associated with liver disease severity. This extrahepatic manifestation is probably secondary to increased bone turnover in osteodystrophy pathogenesis.
Similar content being viewed by others
References
Raisz LG (2005) Clinical practice. Screening for osteoporosis. N Engl J Med 353:164–171
Collier J (2007) Bone disorders in chronic liver disease. Hepatology 46:1271–1278
Hay JE, Guichelaar MM (2005) Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 9:747–766
Leslie WD, Bernstein CN, Leboff MS (2003) AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125:941–966
Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148–154
Crosbie OM, Freaney R, McKenna MJ, Hegarty JE (1999) Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 64:295–300
Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385–390
Collier JD, Ninkovic M, Compston JE (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50(Suppl 1):i1–i9
WHO (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6:35–47
Yucel AE, Kart-Koseoglu H, Isiklar I, Kuruinci E, Ozdemir FN, Arslan H (2004) Bone mineral density in patients on maintenance hemodialysis and effect of chronic hepatitis C virus infection. Ren Fail 26:159–164
Luchi S, Fiorini I, Meini M, Scasso A (2005) Alterations of bone metabolism in patients with chronic C virus hepatitis [in Italian]. Infez Med 13:23–27
Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11:1843–1847
Yenice N, Gumrah M, Mehtap O, Kozan A, Turkmen S (2006) Assessment of bone metabolism and mineral density in chronic viral hepatitis. Turk J Gastroenterol 17:260–266
Lo Re V 3rd, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P (2009) Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS 23:2191–2198
Nanda KS, Ryan EJ, Murray BF, Brady JJ, McKenna MJ, Nolan N, O’Farrelly C, Hegarty JE (2009) Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol 7:894–899
El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT (2011) Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol 55:770–776
Wiegard C, Schramm C, Lohse AW (2009) Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis 29:254–261
Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526–1536
Garnero P, Gineyts E, Riou JP, Delmas PD (1994) Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79:780–785
Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 46:32–36
LaForgia J, Dollman J, Dale MJ, Withers RT, Hill AM (2009) Validation of DXA body composition estimates in obese men and women. Obesity (Silver Spring) 17:821–826
Bredella MA, Ghomi RH, Thomas BJ, Torriani M, Brick DJ, Gerweck AV, Misra M, Klibanski A, Miller KK (2010) Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) 18:2227–2233
Huang GS, Chu TS, Lou MF, Hwang SL, Yang RS (2009) Factors associated with low bone mass in the hemodialysis patients—a cross-sectional correlation study. BMC Musculoskelet Disord 10:60
Mauck KF, Clarke BL (2006) Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc 81:662–672
McCaughan GW, Feller RB (1994) Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig Dis 12:223–231
Rouillard S, Lane NE (2001) Hepatic osteodystrophy. Hepatology 33:301–307
Hsu SH, Tsai KS (1997) Different age-related trends of bone and nonbone forms of alkaline phosphatase in Chinese men and women. Clin Chem 43:186–188
Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y, Tsuchida C, Yamamoto K, Ishii Y (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25:59–67
Melton LJ 3rd, Khosla S, Atkinson EJ, O’Fallon WM, Riggs BL (1997) Relationship of bone turnover to bone density and fractures. J Bone Miner Res 12:1083–1091
Tsai KS, Pan WH, Hsu SH, Cheng WC, Chen CK, Chieng PU, Yang RS, Twu ST (1996) Sexual differences in bone markers and bone mineral density of normal Chinese. Calcif Tissue Int 59:454–460
Acknowledgments
We thank Dr. Daniel Steve Villarreal for English-language editing and Ms. Yu-Ting Hsu for help in picture editing. We also thank the patients who participated in this study. This study was supported in part by a grant from the Foundation for Medical Research of Tri-Service General Hospital (TSGH-C99-167).
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lin, JC., Hsieh, TY., Wu, CC. et al. Association Between Chronic Hepatitis C Virus Infection and Bone Mineral Density. Calcif Tissue Int 91, 423–429 (2012). https://doi.org/10.1007/s00223-012-9653-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-012-9653-y